The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Félicie Faucon Andersen, Denmark
  • Thomas Ø. Tange, Howard Hughes Medical Institute, United States
  • Thayaline Sinnathamby, Molekylærbiologisk Institut, Denmark
  • Jens Raabjerg Olesen, Denmark
  • Kirsten E. Andersen, Denmark
  • Ole Westergaard, Denmark
  • Jørgen Kjems
  • Birgitta R. Knudsen
Human topoisomerase I interacts with and phosphorylates the SR-family of RNA splicing factors, including ASF/SF2, and has been suggested to play an important role in the regulation of RNA splicing. Here we present evidence to support the theory that the regulation can go the other way around with the SR-proteins controlling topoisomerase I DNA activity. We demonstrate that the splicing factor ASF/SF2 inhibits relaxation by interfering with the DNA cleavage and/or DNA binding steps of human topoisomerase I catalysis. The inhibition of relaxation correlated with the ability of various deletion mutants of the two proteins to interact directly, suggesting that an interaction between the RS-domain of ASF/SF2 and a region between amino acid residues 208-735 on topoisomerase I accounts for the observed effect. Consistently, phosphorylation of the RS-domain with either topoisomerase I or a human cell extract reduced the inhibition of relaxation activity. Taken together with the previously published studies of the topoisomerase I kinase activity, these observations suggest that topoisomerase I activity is shifted from relaxation to kinasing by specific interaction with SR-splicing factors.
Original languageEnglish
JournalJournal of Molecular Biology
ISSN0022-2836
Publication statusPublished - 2002

See relations at Aarhus University Citationformats

ID: 11934503